Standard Lithium (NYSEAMERICAN:SLI - Get Free Report) is expected to announce its earnings results before the market opens on Thursday, May 8th. Analysts expect Standard Lithium to post earnings of ($0.03) per share for the quarter.
Standard Lithium Trading Up 5.1 %
SLI stock traded up $0.07 during trading on Tuesday, reaching $1.45. 570,446 shares of the stock were exchanged, compared to its average volume of 1,670,520. The business has a 50 day moving average price of $1.33 and a 200-day moving average price of $1.57. Standard Lithium has a 1 year low of $1.07 and a 1 year high of $2.64. The firm has a market capitalization of $250.47 million, a price-to-earnings ratio of -6.59 and a beta of 1.81.
About Standard Lithium
(
Get Free Report)
Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. The company was formerly known as Patriot Petroleum Corp. and changed its name to Standard Lithium Ltd.
Further Reading

Before you consider Standard Lithium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Standard Lithium wasn't on the list.
While Standard Lithium currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.